Weil Pharmaceutical announced that the company's share repurchase plan plans to use 50 million yuan to 10 million yuan of its own and self-funded funds to repurchase shares through centralized bidding for employee stock ownership plans or equity incentives. The repurchase price will not exceed 40.11 yuan/share, and the repurchase period will be from September 30, 2026 to September 29, 2027. As of November 12, 2026, the company had repurchased 2.7088 million shares, accounting for 2.00% of the total share capital. The repurchase price range was 25.58 yuan/share - 28.00 yuan/share, with a total payment capital of 72.6938 million yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.